4.1 Review

The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets

Journal

FUTURE VIROLOGY
Volume 13, Issue 12, Pages 863-887

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/fvl-2018-0120

Keywords

herpesvirus; oncoprotein; proteomics; signal transduction; transformation; tumor virus; exosomes; extracellular vesicles

Categories

Funding

  1. National Institutes of Health [RO1CA204621, R15CA188941]

Ask authors/readers for more resources

The oncogenic potential of Epstein-Barr virus (EBV) is mostly attributed to latent membrane protein 1 (LMP1), which is essential and sufficient for transformation of fibroblast and primary lymphocytes. LMP1 expression results in the activation of multiple signaling cascades like NF-B and MAP kinases that trigger cell survival and proliferative pathways. LMP1-specific signaling events are mediated through the recruitment of a number of interacting proteins to various signaling domains. Based on these properties, LMP1 is an attractive target to develop effective therapeutics to treat EBV-related malignancies. In this review, we focus on LMP1-interacting proteins, associated signaling events and potential targets that could be exploited for therapeutic strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available